Royalty Pharma plc
← Back to RPRX Overview

Royalty Pharma plc (RPRX)

Revenue & Top-Line Growth

Latest Revenue

$630.6M

Financial Fundamentals

RPRXQuarterly Data • 5Y View

Historical Revenue Data

Quarterly Revenue Breakdown

DateRevenue ($B)QoQ %YoY %TTM ($B)TTM %
2026-03-310.63B+1.4%+11.0%2.44B+7.8%
2025-12-310.62B+2.1%+4.8%2.38B+5.1%
2025-09-300.61B+5.3%+7.9%2.35B+3.7%
2025-06-300.58B+1.8%+7.7%2.31B+3.0%
2025-03-310.57B-4.3%+0.0%2.26B+1.1%
2024-12-310.59B+5.1%-0.4%2.26B-3.9%
2024-09-300.56B+5.1%+5.3%2.27B-2.5%
2024-06-300.54B-5.4%-0.2%2.24B-5.2%
2024-03-310.57B-4.7%-17.0%2.24B-5.1%
2023-12-310.60B+11.1%+5.4%2.35B+5.2%
2023-09-300.54B-0.4%-6.5%2.32B+3.4%
2023-06-300.54B-21.3%+0.4%2.36B+4.5%
2023-03-310.68B+20.9%+21.7%2.36B+3.5%
2022-12-310.57B-1.3%-1.7%2.24B-2.3%
2022-09-300.57B+7.0%-2.1%2.25B-1.7%
2022-06-300.54B-4.6%-3.4%2.26B+0.9%
2022-03-310.56B-2.4%-1.9%2.28B+3.8%
2021-12-310.58B-1.7%+0.6%2.29B+7.9%
2021-09-300.59B+5.6%+8.8%2.29B+13.9%
2021-06-300.55B-3.2%+8.6%2.24B+15.8%
2021-03-310.57B+0.2%+14.4%2.19B+16.7%
2020-12-310.57B+6.3%+25.1%2.12B+17.0%
2020-09-300.54B+5.4%+16.0%2.01B
2020-06-300.51B+2.0%+11.7%1.93B
2020-03-310.50B+9.5%+15.2%1.88B
2019-12-310.46B-1.5%1.81B
2019-09-300.46B+1.5%0.00B
2019-06-300.46B+5.2%0.00B
2019-03-310.43B0.00B

Annual Revenue

YearTotal Revenue ($B)Growth %
20252.38B+5.1%
20242.26B-3.9%
20232.35B+5.2%
20222.24B-2.3%
20212.29B+7.9%
20202.12B+17.0%
20191.81B+1.1%
20181.79B+12.3%
20171.60B-14.9%
20161.88B+13.6%
20151.65B